Congratulations Vital Metrix for being published in Invasive Cardiology and Cath Lab Digest.
Cath Lab Digest
Oct 23, 2019
Vital Metrix, Inc. is developing a patented data analysis solution to enable rapid and reliable non-invasive measurement of cardiac flow and pressure parameters for physician offices and hospitals. After receiving FDA clearance, the Vital Metrix technology will enable physicians and staff to access this vital information and improve the care of patients living with congestive heart failure. Adoption of Vital Metrix will enable clinicians to frequently evaluate and adjust treatment, which can lead to more cost-effective heart failure management.
“Congestive heart failure remains one of the most challenging, and deadliest health challenges in America today, and improved cardiac output measurement can make huge strides in taking on this challenge,” said James Johnson, managing director, MedTech Breakthrough. “Vital Metrix’s work to develop a non-invasive, periodic or continuous, cost-effective cardiac output measurement in the clinical setting is a breakthrough innovation that we are excited to recognize in our annual MedTech Breakthrough Awards program.”
Read the full article in Invasive Cardiology here.
Read the full article in Cath Lab Digest here.